Cardiovascular Disease Doctors in Somerset, KY Accepting Medicare

3 Cardiovascular Disease doctors found. Showing 1 - 3

Mrs. Ginger Renee Combs, ARNP RN Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 55 Thannoli Dr, Somerset, KY 42503 Phone: 606-677-0854    Fax: 606-677-9311

Ibraiz Iqbal, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 104 Hardin Ln, Suite B, Somerset, KY 42503 Phone: 606-677-1112    Fax: 606-679-1341

Natarajan Thannoli, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 55 Thannoli Dr, Somerset, KY 42503 Phone: 606-677-0854    Fax: 606-677-9311

News Archive

Exposure to chemical weapons results in lifelong physical and mental ill-health

People exposed to chemical warfare agents often incur chronic damage to their lungs, skin and eyes, for example. They also frequently succumb to depression, anxiety and suicidal thoughts. This is shown by research on survivors from the 1988 gas attacks against Kurdish Halabja in Iraq.

Alberta collaborates with Janssen to advance early-stage technologies related to diabetes

The Alberta Diabetes Institute at the University of Alberta has announced a new collaboration with Janssen Inc. in Canada to advance early-stage technologies related to Type I and Type II diabetes. Janssen is part of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Researchers investigate how CF patients respond to COVID-19

So far, based on clinical data, patients with cystic fibrosis (CF) don't appear to be especially susceptible to COVID-19, and when they do get infected, they don't seem to get sicker. But Ruobing (Ruby) Wang, MD, a physician-scientist in the Division of Pulmonary Medicine at Boston Children's Hospital, cares for patients with CF and thinks there is more to the story.

Early menstrual cycle could play role in development of ER-negative breast cancer among African-American women

Early age at menarche, or first menstrual cycle, could play a role in the disproportionate incidence of estrogen receptor (ER)-negative breast cancers diagnosed among African-American women, according to a study published in the Journal of the National Cancer Institute.

Eribulin shows increased benefit among women sharing certain traits

Subgroup analyses from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate, with capecitabine, a standard chemotherapy medication in women with previously treated metastatic breast cancer, showed increased benefit among women sharing certain traits.

Read more Medical News

› Verified 9 days ago